SAShaheen Ahmed

Shaheen Ahmed

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shaheen Ahmed has a total of 36 co-authors. Here are the top co-authors by number of shared publications:

  • Abdul Hafeez Shaikh

    Department of Oral and Maxillofacial Surgery, Dow International Dental College, Dow University of Health Sciences, Karachi, Pakistan

    4 shared publications
  • Mehak Anis

    Department of Oral and Maxillofacial Surgery, Baqai Dental College, Baqai Medical University, Karachi, Pakistan

    3 shared publications
  • Muhammad Asif Qureshi

    Department of Pathology, Dow International Medical College, Dow University of Health Sciences, Karachi, Pakistan

    3 shared publications
  • Saeed R. Khan

    Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, USA

    3 shared publications
  • Nouman Mughal

    Department of Biological & Biomedical Science, Aga Khan University Hospital, Karachi, Pakistan

    2 shared publications
  • Raheel Memon

    Department of Oral and Maxillofacial Surgery, Dow International Dental College, Dow University of Health Sciences, Karachi, Pakistan

    2 shared publications

Latest Publications

  • Open Access

    Expressional patterns of p53: an association with KAISO, clinicopathological characteristics, and field cancerization of OSCC

    by Shaheen Ahmed, Saeed Khan, Muhammad Asif Qureshi, Soofia Jamil, Mehak Anis, Waqas Ahmed

  • Open Access

    Investigation of the expression of the C-terminal cross-linking telopeptide of type I collagen (CTXI) in saliva during early and delayed loading of dental implants

    by Dania Hamid, Shaheen Ahmed, Abdul Hafeez Shaikh, Sadaf Nisar, Raheel Memon, Samreen Malik

    Implants are commonly used as a treatment choice for partially dentate or edentulous patients. Currently, no specific biomarker for assessing the bone status around dental implants of healthy patients has been reported for evaluating bone deposition, resorption, or stability. CTXI (C-terminal telopeptide of type I collagen) is a known specific biomarker for bone resorption. However, CTXI levels in the saliva of healthy patients with dental implants have not been investigated. This randomized controlled trial aimed to evaluate salivary CTXI levels in dental implant patients with early and delayed loading and to compare them with the values of the periotest to determine implant stability and loading time. This study was conducted in Karachi, Pakistan, and included 40 patients with dental implants placed in the posterior mandible. Patients were randomly divided into two groups based on the timing of implant loading: an early loading group, where implants were functionally loaded within 1 month of placement, and a delayed loading group, where implants were loaded after 3 months. The intervention involved functional loading of the implants according to the assigned group. Implant stability was assessed using a periotest on the day of surgery and at 1 month or 3 months, depending on the group. Additionally, saliva samples were collected from all patients at 1 month and 3 months to evaluate CTXI expression levels using sandwich ELISA. A comparison by periotest showed that dental implants were stable in the early loading group and that osseointegration was good; thus, loading could be applied within one month of dental implant placement. However, in our study, the CTXI bone turnover marker was not detected in any group and thus cannot be used to indicate bone implant stability or loading time. This study demonstrates that early loading of dental implants can achieve stability and osseointegration within one month, as confirmed by Periotest measurements. However, salivary CTXI levels were undetectable in both early and delayed loading groups, indicating that this biomarker is unsuitable for assessing bone-implant stability or determining the optimal timing for implant loading in healthy patients. These findings suggest further research to explore alternative biomarkers for non-invasive osseointegration and implant stability monitoring. Retrospectively registered, ID: NCT06246097, Date of registration: 07/02/2024, ( https://clinicaltrials.gov/ct2/show/NCT06246097 ).

  • Open Access

    Efficacy of Submucosal versus Pterygomandibular Dexamethasone Injection in Surgical Extraction of the Impacted Lower Third Molar

    by Shaheen Ahmed, Usman Ashraf, Abdul Hafeez Shaikh, Soofia Jamil, Syed Jaffar Abbas Zaidi, Qaiser Ali Baig

    Objectives: This study aimed to evaluate the efficacy and postoperative complications of preoperative submucosal dexamethasone injection compared to preoperative dexamethasone injection into the pterygomandibular space for surgical extraction of the impacted lower third molar. Study design and setting: This was a quasi-experimental, cross-sectional study conducted at the Department of Oral and Maxillofacial Surgery, Dow International Dental College, Dow University of Health Sciences, Karachi, from April to July 2021. Methodology: The study sample consisted of 72 patients who reported surgical extraction of their lower wisdom teeth and consented to participate in this study. The patients were randomly divided into the submucosal injection group (SM) and the pterygomandibular space (PM) group. The injection time was recorded on the second and seventh postoperative days. Results: No significant differences in the duration of the intervention were observed between the two groups (23.08 min in PM, 23.07 min in SM). The postoperative facial swelling was significantly reduced transversely (ear lobe to the angle of the mouth) in both groups compared to their respective baselines on the first postoperative day. On the secondpostoperative day, significant changes were observed in the submucosal group in postoperative swelling. Conclusions: Using intraoral dexamethasone injections in third molar surgery significantly reduces conventional complications of surgery while avoiding the systemic side effects of steroids. Dexamethasone should be used regardless of the administration site when warranted, with less apprehension than is common in dentistry


  • Open Access

    Analyzing the Salivary Levels of Cathepsin B in Oral Submucous Fibosis and Oral Squamous Cell Carcinoma for Early Detection

    by Shaheen Ahmed, Alveena Shabbir, Abdul Shaikh, Soofia Jamil, Sabhita Shaikh, Waqas Farooqui

    Background: Oral squamous cell carcinoma is one of the most prevalent and common cancers of oral cavity with significant higher rates of mortality and morbidity. Many of the OSCC are known to be preceded by oral potentially malignant disorders such as Oral Submucous Fibrosis. OSF is a chronic and insidious condition with a high malignant transformation potential into OSCC. Salivary biomarker analysis has been considered as a promising approach for early detection of malignant potential of OSF. Cathepsin B is a lysosomal cysteine protease. In many malignancies increased levels of Cathepsin B were observed including OSCC. The present study was designed to analyze and determine the salivary Cathepsin B levels in OSF and OSCC. Method: 150 research participants in total were included in this study which were further divided into 3 groups, 50 in each group. Group 1 comprised 50 OSF patients, Group 2 comprised 50 OSCC patients and group 3 comprised 50 control group. Salivary Cathepsin B levels were analyzed in all 3 groups by using ELISA technique after saliva sample collection. Results: Cathepsin B salivary levels were found to be increased significantly in both OSF and OSCC patients in comparison to control group with significant higher < 0.001 p-value. Highest mean salivary Cathepsin B levels were found in OSF 9.50s ± 7.3, followed by OSCC 4.54 ± 5.9 and control group 0.45s ± 0.9 respectively. Conclusion: Cathepsin B salivary levels were observed to be increased significantly both in patients of OSF and OSCC. Therefore, Cathepsin B can be considered a useful and beneficial salivary biomarker for early detection of OSCC.

  • Open Access

    Expression of Neurotensin and Neurotensin Receptor1 in Human Oral Squamous Cell Carcinoma: A Potential Role in Tumor Depth and Nodal Metastasis

    by Soofia Jamil, Abdul Hafeez Shaikh, Shaheen Ahmed, Hira Salam, Sidra Zaheer, Nouman Mughal

    World’s sixth most prevalent cancer is Oral squamous cell carcinoma (OSCC) which is a malignant neoplasm developing in the epithelial tissues of the oral cavity. In Pakistan, it is amongst the most commonly reported malignancies in both genders owing to widespread use of risk factors, including betel nut, smoking, gutka etc. Advance disease, presence of cervical lymphadenopathy and late presentation leads to poor 5-year survival. Certain variables have been studied as predictors of metastasis of which depth of invasion of tumor is directly correlated to it. Neurotensin, a 13 amino-acid neuropeptide mediates its effects via three receptors, out of which 2 are G-protein coupled receptors NTR1 & 2 alongwith the sole transmembrane domain receptor, NTR3. Aberrant expression and localization has been reported in various tumors and associated with increase tumor depth and aggressiveness. Methodology: Histological grading was performed using Broder’s criteria. H&E staining for evaluation of tumor depth analysis. Immunohistochemical staining was used to study expression and localization of NT, NTR1 in each sample. Results: Expressional analysis of NTS and its receptor NTR1 in oral squamous cell carcinoma revealed that ~ 62% of all tumor tissues were positive for neurotensin expression. High-affinity receptor for neurotensin NTR1 was expressed in 79% of OC sample tissues. We investigated tumor depth for any correlation with NTS/NTR1 expression. Overall a moderate intensity of expression was observed in all the tissues but it could be observed that as the tumor depth increased from < 5mm to > 10mm, neurotensin expressional profile also increased in terms of IRS scores. Tumor depth was measured from basement membrane to the deepest point of invasion. Mean tumor depth was estimated to be 15.02mm with majority of the tumors displaying tumor depth greater than 10mm. Conclusion: Our study demonstrated a general trend towards a higher expressional gradient of neurotensin correlating with increasing depth of invasion which is known to be an independent predictor of the OC prognosis. Also, this indicates a potential role of this peptide in determining the aggressiveness of the disease.

  • Open Access

    Relation of salivary MMP-8 with oral submucous fibrosis and oral squamous cell carcinoma: a cross sectional analytical study

    by Anum Kazmi, Zia Abbas, Zohra Saleem, Safdar Haider, Waqas Ahmed Farooqui, Shaheen Ahmed

    Objectives We aim to evaluate salivary matrix metalloproteinases (MMP-8) levels in oral submucous fibrosis (OSF) and oral squamous cell carcinoma (OSCC) for the purpose of diagnosis at the early stage via non-invasive method. Setting The study was multicentre, carried out at a tertiary care hospital in Karachi, Pakistan. Participants A total 60 participants of any age, sex and ethnicity were randomly selected for the purpose of this study. Patients demonstrating clinical evidence of OSF and biopsy-proven cases of OSCC were included. Patients with indeterminate histopathological report, immunodeficiency, autoimmune disorder, chronic medical and periodontal disease (periodontal depth greater than 5 mm) and individuals with interincisal mouth opening greater than 35 mm were excluded from the study. Interventions Salivary MMP-8 levels were observed in OSF, healthy and OSCC groups by using ELISA. One way analysis of variance was applied to establish whether MMP-8 levels of disease-free individuals and patients suffering from OSF and OSCC differed from each other. Results Statistically significant difference in salivary MMP-8 expression in diseased and control group was observed. MMP-8 levels in OSCC (0.64 ng/mL) and OSF (0.66 ng/mL) were underexpressed as compared with healthy participants (7.9 ng/mL). Conclusion MMP-8 levels were underexpressed in OSCC and OSF patients as compared with controls, which imply that MMP-8 level has an inverse relation with OSCC and OSF.


  • Open Access

    Expressional variations of Kaiso: an association with pathological characteristics and field cancerization of OSCC

    by Shaheen Ahmed, Saeed Khan, Muhammad Asif Qureshi, Uzma Bukhari, Mehak Anis, Muhammad Nouman Mughal

    Background: A group of genetically altered cells that have not transformed into a clinical or histologically identifiable state of malignancy but contains a higher risk of transforming into one is known as the field of cancerization. Numerous molecules are being investigated for their significance in the development of this phenomenon. One such protein of this family is Kaiso also known as ZBTB33 (Zinc Finger and BTB Domain containing 33). This protein belongs to the POZ-ZF family of transcription factors and may have functional tasks similar to its other siblings such as the growth and development of vertebrates and the pathogenesis of neoplastic diseases. Nevertheless, its role in the pathogenesis, progression, epithelial mesenchyal transition and field cancerization in case of oral cancer still needs exploration. Hence, this study was designed to explore the expressional differences between the mucosa of controls and those diagnosed with oral squamous cell carcinoma (OSCC). Methods: Soft tissue samples were obtained from the main tumor, tumor periphery and opposite buccal mucosa of 50 oral cancer patients, whereas normal mucosa was taken from 50 volunteers undergoing elective tooth removal. The acquired samples were subjected to Immunohistochemical exploration for expression of Kaiso and E-Cadherin. The expression was measured using Image-J IHC profiler and summed as Optical density. The Optical density values were then subjected to statistical analysis. Results: Results revealed a significant differential expression of Kaiso between the mucosal tissues taken from oral cancer patients and controls (p-value: < 0.0001), showing almost 50% down-regulation of Kaiso in all three tissue samples taken from oral cancer patients as compared to normal mucosa. Conclusion: Kaiso has a significant difference of expression in the mucosa of oral cancer patients as compared to the mucosa of normal patients, making it a probable contributor to disease pathogenesis and field cancerization.


  • Open Access

    Evaluating the effects of frequency and duration of tobacco use on oral mucosa in patients visiting Hamdard University Dental Hospital

    by Obaidullah Khan, Abdul Hafeez Shaikh, Shaheen Ahmed, Shikow Naz, Raheel Memon, Qaiser Ali Baig

    Background Use of tobacco in any form (Smoke or Smokeless) is one of the most popular habits around the globe that over one billion people routinely consume tobacco products like cigrates, chalia, pan, niswar (1). Almost 23.9 million Pakistani adults currently use tobacco in any form like cigarettes smoking, betel nut, betel quid, pan chalia, are all well recognized habits in developing oral lesions including precancerous and cancerous lesions like Smokers melanosis, Submucous fibrosis, Lichen Planus, Leukoplakia, Oral Squamous cell Carcinoma (OSCC) etc(2). Location and type of oral mucosal lesions varies with the way tobacco is consumed along with its frequency and duration. Objectives Objective of the current study is to assess the effects of frequency and duration of tobacco (Smoke and Smokeless) use on oral mucosa among patients reported at Hamdard University Dental Hospital. Methods The study designed as case-control and data has been collected from 280 individuals who were tobacco users categorized in groups of smokers, chewers and mixed according to their habits. Half of the subjects were assigned as cases (diagnosed with oral mucosal lesion) and the remaining half assigned as controls (who were lesion free). The study protocol includes questionnaire-based interview along with clinical examination of Oral cavity. Statistical assessment has been performed with SPSS 16.0 software guided with Chi square test and association of the variables with the lesions would be assessed through multiple logistic regression analysis. Results Eight different types of mucosal lesions noticed in the oral cavity among patients who have habits of smoking (cigrates), chewing (betel nuts) and mixed habits (Smoking and chewing). Out of which Leukoplakia found to be the commonest lesion within oral cavity following OSF (Oral submucous fibrosis) and smoker’s melanosis. Conclusion Outcomes of this study shows valuable data on association of oral lesions in patients who were involved in the habits of smoking, chewing and both (mixed). Few precancerous and cancerous conditions like oral squamous cell carcinoma were also encountered along with other mucosal lesions. Males were more prevalent in these habits than females therefore the majority of the lesions found in men. Moreover, increase in the frequency and duration of habits significantly increases the risk of developing lesions in case population.

  • Open Access

    Expressional Variations of Kaiso: An Association with Pathological Characteristics and Field Cancerization of OSCC

    by Shaheen Ahmed, Saeed Khan, Asif Qureshi, Uzma Bukhari, Nouman Mughal, Mehak Anis

    Background: In patients diagnosed with cancer it is considered that there is a field of tissue in the diagnosed organ containing cells with genetic aberration which pose a higher risk of transforming in to premalignant and malignant lesions. This field of altered cells is known as field of cancerization and is considered responsible for frequent recurrence of the cancer. Various molecules are being investigated for their significance in development of field cancerization and hence malignant diseases. Various members of POZ-ZF (poxvirus and zinc finger (POZ)-zinc finger) family of transcription factors are known to play a part in pathogenesis of neoplasm, one such protein of this family is Kaiso also known as ZBTB33 ( Zinc Finger and BTB Domain containing 33. Kaiso is a transcription factor known for having two modes of binding with DNA. The protein belongs to POZ-ZF family of transcription factors and may have functional tasks similar to its other siblings such as growth and development of vertebrates and pathogenesis of neoplastic diseases. Nevertheless, its role in field cancerization, pathogenesis and progression of oral cancer still needs exploration. Hence, this study was designed to explore the expressional differences between the mucosa of controls and those diagnosed with OSCC. Methods: Soft tissue samples were obtained from main tumor, tumor periphery and opposite buccal mucosa of 50 oral cancer patients, whereas normal mucosa was taken from 50 volunteers undergoing elective tooth removal. The acquired samples were then subjected to Immunohistochemical exploration for expression of Kaiso. The expression was measured using Image-J IHC profiler and summed as Optical density. The Optical density values were then subjected to statistical analysis. Results: Results revealed a significant differential expression of Kaiso between the mucosal tissues taken from oral cancer patients and controls (p-value: Conclusion: Kaiso have significant difference of expression in the mucosa of oral cancer patients than the normal mucosa making it a probable contributor to disease pathogenesis and field cancerization.

  • Open Access

    Hematological study of patients with recurrent aphthous stomatitis - Case control study

    by Shaheen Ali Ahmed, Ali Fakhree Alzubaidee

    Background and Objectives: Recurrent aphthous stomatitis is common oral condition, characterized by multiple, recurrent, small, round, or ovoid ulcers with circumscribed, erythematous haloes, and yellow or grey floors. Its etiology and pathogenesis is not entirely clear linked to systemic diseases and among these, anemia, iron deficiency, folic- acid, and vitamin B12 deficiencies. The aim of this study to investigate the association between recurrent aphthous stomatitis and hemoglobin, serum ferritin, folic acid, and vitamin B12 deficiency. Patient and Methods: This prospective cross sectional case control clinical study was conducted on 50 patients with recurrent aphthous stomatitis. The control group composed of 50 healthy age and sex-matched subject. The patient demography about family history of recurrent aphthous stomatitis, and smoking was recorded, also the hemoglobin, serum levels of ferritin, folic acid, and vitamin B12 has been investigated. Results: The low hemoglobin was reported in 30% and vitamin B 12 deficiency in 31% of the patient so low hemoglobin and B12 deficiency have significant correlation with recurrent aphthous stomatitis. Patients with low hemoglobin, vitamin B12 deficiency , positive family history, and non smoker have been found to have the highest risk for having recurrent aphthous stomatitis. Conclusion: Recurrent aphthous stomatitis is a multifactorial disease. Positive family history, low hemoglobin level , vitamin B12 deficiency, and nonsmoking status are among the important predisposing factors. Routine hematological screening and tests for iron status, folic acid, and vitamin B12 status should be assessed in all patients with recurrent aphthous stomatitis.